Lab21, IntegraGen to Develop PCR-Based Assay to Guide Colorectal Cancer Therapy
February 28, 2013
Lab21, IntegraGen to Develop PCR-Based Assay to Guide Colorectal Cancer Therapy
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Lab21, IntegraGen Co-developing CDx for Colorectal Cancer Therapy
February 22, 2013 / GenomeWeb Daily News - Lab21 to Develop microRNA-Based Colorectal Cancer Diagnostic for IntegraGen
February 28, 2013 / Gene Silencing News - Studies Show Promise of Inostics' BEAMing Tech to Detect Drug Resistance Markers in Cancer Patients
June 28, 2012 / PCR Insider - Royalties Drive up GeneNews Q1 Revenues Sharply
May 16, 2013 / GenomeWeb Daily News - Transgenomic to Develop RAS Mutation Test with Amgen for Metastatic CRC Patients
May 15, 2013 / Pharmacogenomics Reporter